Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avital Beig

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Biomedical Chromatography : BMC|December 12, 2013
Quantification of carbamazepine and its 10,11-epoxide metabolite in rat plasma by UPLC-UV and application to pharmacokinetic studyAvital Beig, Arik Dahan
Plos One|July 23, 2013
Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulationsAvital Beig, Riad Agbaria, Arik Dahan
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 27, 2015
The use of captisol (SBE7-β-CD) in oral solubility-enabling formulations: Comparison to HPβCD and the solubility-permeability interplayAvital Beig, Riad Agbaria, Arik Dahan
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 6, 2012
Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorptionAvital Beig, Jonathan M Miller, Arik Dahan
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 18, 2013
The interaction of nifedipine with selected cyclodextrins and the subsequent solubility-permeability trade-offAvital Beig, Jonathan M Miller, Arik Dahan
International Journal of Pharmaceutics|January 26, 2021
Adequate formulation approach for oral chemotherapy: Etoposide solubility, permeability, and overall bioavailability from cosolvent- vs. vitamin E TPGS-based delivery systemsNoa Fine-Shamir, Avital Beig, Arik Dahan
International Journal of Pharmaceutics|July 9, 2023
In vitro performance of composition-equivalent PLGA microspheres encapsulating exenatide acetate by solvent evaporationAishwarya Chandrashekar, Avital Beig, Yan Wang, et al.
Molecular Pharmaceutics|December 17, 2016
Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood LevelsAvital Beig, Jonathan M Miller, David Lindley, et al.
Advanced Drug Delivery Reviews|May 1, 2016
The solubility-permeability interplay and oral drug formulation design: Two heads are better than oneArik Dahan, Avital Beig, David Lindley, et al.
International Journal of Pharmaceutics|April 11, 2020
The solubility, permeability and the dose as key factors in formulation development for oral lipophilic drugs: Maximizing the bioavailability of carbamazepine with a cosolvent-based formulationNoa Fine-Shamir, Avital Beig, Jonathan M Miller, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Biomedical Chromatography : BMC|December 12, 2013
Quantification of carbamazepine and its 10,11-epoxide metabolite in rat plasma by UPLC-UV and application to pharmacokinetic studyAvital Beig, Arik Dahan
Plos One|July 23, 2013
Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulationsAvital Beig, Riad Agbaria, Arik Dahan
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 27, 2015
The use of captisol (SBE7-β-CD) in oral solubility-enabling formulations: Comparison to HPβCD and the solubility-permeability interplayAvital Beig, Riad Agbaria, Arik Dahan
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 6, 2012
Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorptionAvital Beig, Jonathan M Miller, Arik Dahan
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 18, 2013
The interaction of nifedipine with selected cyclodextrins and the subsequent solubility-permeability trade-offAvital Beig, Jonathan M Miller, Arik Dahan
International Journal of Pharmaceutics|January 26, 2021
Adequate formulation approach for oral chemotherapy: Etoposide solubility, permeability, and overall bioavailability from cosolvent- vs. vitamin E TPGS-based delivery systemsNoa Fine-Shamir, Avital Beig, Arik Dahan
International Journal of Pharmaceutics|July 9, 2023
In vitro performance of composition-equivalent PLGA microspheres encapsulating exenatide acetate by solvent evaporationAishwarya Chandrashekar, Avital Beig, Yan Wang, et al.
Molecular Pharmaceutics|December 17, 2016
Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood LevelsAvital Beig, Jonathan M Miller, David Lindley, et al.
Advanced Drug Delivery Reviews|May 1, 2016
The solubility-permeability interplay and oral drug formulation design: Two heads are better than oneArik Dahan, Avital Beig, David Lindley, et al.
International Journal of Pharmaceutics|April 11, 2020
The solubility, permeability and the dose as key factors in formulation development for oral lipophilic drugs: Maximizing the bioavailability of carbamazepine with a cosolvent-based formulationNoa Fine-Shamir, Avital Beig, Jonathan M Miller, et al.
Pageof 3